MetaCap

Upstream Bio Statistics

NASDAQ: UPBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.59-0.41 (-20.50%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Upstream Bio by the numbers

Upstream Bio has a market capitalization of $87.2 million based on 54.81M shares outstanding. With trailing EPS of $-3.01, Upstream Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 58.6% below its 50-day average and 77.9% below its 200-day average.

Average daily trading volume is 1.01M shares, or about $1.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

UPB valuation vs. peer median

UPB compared with the median of 8 peer companies
MetricUPBPeer medianDifference
Market cap$87.15M$87.41M-0%
Avg. volume1.01M306.02K+229%

Peer median across 8 companies: EQ, RTSN, CPIX, ANIX, NTHI, CATX, OGI, HURA.

Valuation

Market cap
$87.15M
Price / sales (latest FY)
30.54
EPS (TTM)
$-3.01

Price and trading

Previous close
2.00
Open
1.98
Day range
1.56 – 2.06
52-week range
1.56 – 33.68
52-week change
-93.78%
Beta
—
Volume
1.39M

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
87.15M
Forward Pe
-0.60
Eps
-3.01
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
33.68
Week52 Low
1.56
Avg Volume
1.01M
Shares Outstanding
54.81M
Ma50
3.84
Ma200
7.20
Earnings Date
Nov 10, 2026
Pct From52w High
-95.28%
Pct From52w Low
1.92%

Related